Perrigo | PRGO - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
AbbVie USD 6.72B 1.99B 2026-06
Abbott USD 2.13B 281M 2026-06
Bayer EUR 827M 2.7B 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Coherus Biosciences USD -39.08M 3.65M 2025-12
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Dr.Reddys Laboratories INR 3.25B 2.36B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
J&J USD 7.48B 860M 2026-06
Merck USD 840M 2.72B 2026-06
Nestle CHF 6.98B 133M 2026-06
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 23.5M 10.1M 2026-06
Pfizer USD 667M 4.32B 2026-06
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Reckitt Benckiser GBP 747M 92M 2024-12
Sanofi EUR 2.38B 449M 2026-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
Xeris Pharmaceuticals USD 7.92M 8.86M 2026-03
Zoetis USD 1.12B 256M 2026-06